MD Anderson Cancer Center shared on X:
“Patients with newly diagnosed multiple myeloma may benefit from Isa-VRd as initiation therapy, our Dr. Robert Orlowski reported at ASH24 to an audience spilling over into three overflow rooms.”
Photo of Robert Z. Orlowski from faculty.mdanderson.org